Date: 2012-05-30
Type of information: Services contract
Compound: R&D services related to Phase II-IV clinical studies and central laboratory services
Company: Bayer (Germany) Covance (USA)
Therapeutic area:
Type agreement: R&D
clinical research
development
Action mechanism:
Disease:
Details: Bayer HealthCare and Covance have decided to establish a long-term strategic partnership in the area of clinical drug development including R&D services related to Phase II-IV clinical studies and central laboratory services. The new strategic partnership marks a next level of the broad-based cooperation both partners have developed over the past years and represents the efforts to maximize its benefits across the Bayer HealthCare organization. Bayer’s goal is to better leverage Covance’s broad range of experience and services across the R&D portfolio to attain best in class operational delivery, efficiency and quality whilst also delivering significant financial benefits to both organizations.
Financial terms:
Latest news:
